Gallant
San Diego
About Gallant
Gallant is developing a scalable stem cell therapy platform that will allow any veterinarian to routinely treat pets in a primary care setting, improving the lives of pets and their people. By systematically addressing challenges that previously hindered stem cell therapy adoption, the company aims to make stem cell products accessible in order to elevate the quality of life for all pets and the people that love them.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $44.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2025)
- Website: gallant.com
- Phone: +855 44 255 268
Industries & Categories
Biotechnology, Pet, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/gallant-67144 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.